Treatment Action Group (TAG), with funding from Wellcome and support from the TB Vaccine Advocacy Roadmap (TB Vax ARM) coalition, has opened a call for expressions of interest under its “Architects of Trust” programme, which funds community-driven demand creation for new TB vaccines.
The call opened 19 October 2026 with an introductory webinar on 28 October.
First-stage expressions of interest are due 4 November 2026 at 23:59 Pacific Time, with outcomes announced 4 December 2026, a second-stage workplan and budget due 11 January 2027, selected organizations notified 27 January 2027, and projects starting 1 March 2027. Eligible applicants are civil society or community-based organizations working at national, subnational or regional level in Brazil, Ethiopia, India, Indonesia, Kenya, Malawi, Mozambique, Nigeria, Peru, the Philippines, South Africa, Tanzania, Viet Nam and Zambia, plus regional networks in Eastern Europe and Central Asia, with experience in TB, immunization or health advocacy and a project lead able to attend an in-person forum in Zaragoza, Spain, on 12–16 April 2027. Up to eight partners will each receive up to US$45,000 for 12 months of advocacy, policy engagement and community demand-creation work, plus training, technical assistance and a mentor from TB Vax ARM.
More information is available on the Treatment Action Group website.
